Literature DB >> 10689155

Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space.

C Franceschi1, M Bonafè, S Valensin.   

Abstract

According to the remodeling theory of aging we proposed several years ago, the current data on human immunosenescence depicts a complex scenario where clonotypical immunity deteriorates, while ancestral innate/natural immunity is largely conserved or even up-regulated with age. Under an evolutionary perspective, antigens are the cause of a persistent life-long antigenic stress, responsible for the accumulation of effector CD8+/CD28- T cells, the decrease of naive T cells (CD95-) and the marked shrinkage of T cell repertoire with age. Concomitantly, NK cytotoxicity, chemotaxis, phagocytosis and complement activities remain unaffected or negligibly affected, in comparison to clonotypical immunity. Thus, immunosenescence is not a random deteriorative phenomenon but appears to inversely recapitulate an evolutionary pattern. On the whole, immunosenescence can be envisaged as the result of the continuous challenge of the unavoidable exposure to a variety of potential antigens (viruses, bacteria, but also food and self molecules among others). From this perspective antigens are nothing else than a particular type of stressor and immunosenescence appears to be the price paid to immunological memory, i.e. one of the main characteristics of the most evolutionary recent and sophisticated type of immunity. Together with the age-related thymic involution, and the consequent age-related decrease of thymic output of new T cells, this situation leaves the body practically devoid of virgin T cells, and thus likely more prone to a variety of infectious and non infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10689155     DOI: 10.1016/s0264-410x(99)00513-7

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  130 in total

Review 1.  Dendritic cells and aging: consequences for autoimmunity.

Authors:  Anshu Agrawal; Aishwarya Sridharan; Sangeetha Prakash; Harsh Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

2.  Mitigating cellular inflammation in older adults: a randomized controlled trial of Tai Chi Chih.

Authors:  Michael R Irwin; Richard Olmstead
Journal:  Am J Geriatr Psychiatry       Date:  2012-09       Impact factor: 4.105

3.  Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old.

Authors:  Qin Ouyang; Wolfgang M Wagner; Anders Wikby; Steffen Walter; Geraldine Aubert; Anthony I Dodi; Paul Travers; Graham Pawelec
Journal:  J Clin Immunol       Date:  2003-07       Impact factor: 8.317

Review 4.  The immune system in the elderly: activation-induced and damage-induced apoptosis.

Authors:  Lia Ginaldi; Massimo De Martinis; Daniela Monti; Claudio Franceschi
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 5.  The immune system in the aging human.

Authors:  Paulina Dominika Rymkiewicz; Yi Xiong Heng; Anusha Vasudev; Anis Larbi
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

6.  Aging and the pathogenic response to burn.

Authors:  Meenakshi Rani; Martin G Schwacha
Journal:  Aging Dis       Date:  2011-07-04       Impact factor: 6.745

7.  Age and facial nerve axotomy-induced T cell trafficking: relation to microglial and motor neuron status.

Authors:  Daniel J Dauer; Zhi Huang; Grace K Ha; Jeremy Kim; David Khosrowzadeh; John M Petitto
Journal:  Brain Behav Immun       Date:  2010-08-19       Impact factor: 7.217

Review 8.  Challenges with Diagnosing and Managing Sepsis in Older Adults.

Authors:  Kalin M Clifford; Eliza A Dy-Boarman; Krystal K Haase; Kristen Maxvill; Steven E Pass; Carlos A Alvarez
Journal:  Expert Rev Anti Infect Ther       Date:  2016-01-14       Impact factor: 5.091

9.  How immunosuppressive therapy affects T cells from kidney transplanted patients of different age: the role of latent cytomegalovirus infection.

Authors:  K Welzl; B Weinberger; A Kronbichler; G Sturm; G Kern; G Mayer; B Grubeck-Loebenstein; C Koppelstaetter
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

Review 10.  Immune monitoring as prerequisite for transplantation tolerance trials.

Authors:  K Behnam Sani; B Sawitzki
Journal:  Clin Exp Immunol       Date:  2017-06-23       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.